Clinical Trial Update: High Ticagrelor Loading Dose in STEMI [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from the University of Florida evaluated a high loading dose of ticagrelor in patients with ST-segment elevation myocardial infarction …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Myocardial Infarction
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• BRILINTA (ticagrelor)

Snippet

Sponsor: University of Florida | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2015-06-08